Table 4:
Any Stage HCC | ||||||
---|---|---|---|---|---|---|
6 months | 12 months | 24 months | ||||
HES positive | HES negative | HES positive | HES negative | HES positive | HES negative | |
GALAD positive | 16 (48.5%) | 3 (9.1%) | 20 (47.6%) | 3 (7.1%) | 21 (42.5%) | 5 (10.2%) |
GALAD positive | 5 (15.2%) | 9 (27.3%) | 5 (11.9%) | 14 (33.3%) | 8 (16.3%) | 15 (30.6%) |
Early Stage HCC | ||||||
HES positive | HES negative | HES positive | HES negative | HES positive | HES negative | |
GALAD positive | 15 (57.7%) | 3 (11.5%) | 18 (60.0%) | 3 (10.0%) | 18 (52.9%) | 5 (14.7%) |
GALAD positive | 1 (3.8%) | 7 (26.9%) | 1 (3.3%) | 8 (26.7%) | 2 (5.9%) | 9 (26.5%) |